Petros Pharmaceuticals Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
PTPI$0.07-46.5%Stored close · as of May 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
Our audited consolidated financial statements as of, and for the years ended December 31, 2023, and December 31, 2022, are included beginning on Page F-1 immediately following the signature page to this Annual Report. See Item15 for a list of the consolidated financial statements included herein.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.